Top

Systematic Reviews

Published in:

01-12-2021 | Prostate Cancer | Research

Health outcomes of sexual and gender minorities after cancer: a systematic review

Authors: Mandi L. Pratt-Chapman, Ash B. Alpert, Daniel A. Castillo

Published in: Systematic Reviews | Issue 1/2021

Abstract

Purpose

Cancer research on sexual and gender minority (SGM) populations is gaining momentum. The purpose of this systematic review was to examine what is currently known in the research literature regarding patient-reported health outcomes after cancer treatment among SGM populations.

Methods

In March 2021, a medical librarian conducted a systematic keyword search on PubMed, Embase, Scopus, Web of Science, PsycINFO, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials. The primary inclusion criterion was assessment of at least one physical, psychosocial, emotional, or functional patient-reported health outcome related to the impacts of cancer diagnosis and/or treatment. Articles that met inclusion criteria were reviewed in their entirety, charted in a Word Table, and assessed for quality. Quality considerations included study design, sampling approach, diversity of sample, measures used, and analytic procedures. Studies were synthesized based on type of cancer study participants experienced.

Results

Sixty-four studies were included in the final analysis: most were quantitative, secondary analyses or cross-sectional studies with convenience samples, and focused on people with a history of breast or prostate cancer. Differences between sexual minority men and women in terms of coping and resilience were noted. Few studies reported on experiences of transgender persons and none reported on experiences of intersex persons.

Conclusions

A growing literature describes the patient-reported health outcomes of SGM people with a history of cancer. This study summarizes important between-group differences among SGM and heterosexual, cisgender counterparts that are critical for clinicians to consider when providing care.

Implications for cancer survivors

Sexual orientation and gender identity are relevant to cancer survivors’ health outcomes. Subgroups of SGM people have differential experiences and outcomes related to cancer and its impacts.

Available only for authorised users

Institute of Medicine (U.S.). Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities. The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. Washington, DC: National Academies Press; 2011.

National Institutes of Health. Sexual and Gender Minority Research Office (SGMRO) website. https://dpcpsi.nih.gov/sgmro. Accessed 5 Jan 2020

Griggs J, Maingi S, Blinder V, Denduluri N, Khorana AA, Norton L, et al. American Society of Clinical Oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol. 2017;35(19):2203–8. https://doi.org/10.1200/JCO.2016.72.0441.CrossRefPubMed

Wheldon CW, Schabath MB, Hudson J, Bowman Curci M, Kanetsky P, Vadaparampil ST, et al. Culturally competent care for sexual and gender minority patients at national cancer institute-designated comprehensive cancer centers. Lgbt Health. 2018;5(3):203–11. https://doi.org/10.1089/lgbt.2017.0217.CrossRefPubMedPubMedCentral

Poteat T, German D, Kerrigan D. Managing uncertainty: a grounded theory of stigma in transgender health care encounters. Soc Sci Med. 2013;84:22–9. https://doi.org/10.1016/j.socscimed.2013.02.019.CrossRefPubMed

James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The Report of the 2015 U.S. Transgender Survey. 2016. https://www.transequality.org/sites/default/files/docs/USTS-Full-Report-FINAL.PDF. Accessed 5 Jan 2020.

Page MJ, McKenzie JE, Bossuyt PM, Bouton I, Hoffman TC, Mulrow CD, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103–12. https://doi.org/10.1016/j.jclinepi.2021.02.003.CrossRefPubMed

Page MJ, McKenzie JE, Bossuyt PM, Bouton I, Hoffman TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.CrossRefPubMedPubMedCentral

Boehmer U, Cooley TP, Clark MA. Cancer and men who have sex with men: a systematic review. Lancet Oncol. 2012;13(12):E545–E53. https://doi.org/10.1016/S1470-2045(12)70347-9.CrossRefPubMed

10.

Boehmer U, Mertz M, Timm A, Glickman M, Sullivan M, Potter J. Overweight and obesity in long-term breast cancer survivors: how does sexual orientation impact BMI? Cancer Investig. 2011;29(3):220–8. https://doi.org/10.3109/07357907.2010.550664.CrossRef

11.

Boehmer U, Glickman M, Milton J, Winter M. Health-related quality of life in breast cancer survivors of different sexual orientations. Qual Life Res. 2012;21(2):225–36. https://doi.org/10.1007/s11136-011-9947-y.CrossRefPubMed

12.

Boehmer U, Timm A, Ozonoff A, Potter J. Explanatory factors of sexual function in sexual minority women breast cancer survivors. Ann Oncol. 2012;23(11):2873–8. https://doi.org/10.1093/annonc/mds099.CrossRefPubMed

13.

Boehmer U, Glickman M, Winter M, Clark MA. Breast cancer survivors of different sexual orientations: which factors explain survivors’ quality of life and adjustment? Ann Oncol. 2013;24(6):1622–30. https://doi.org/10.1093/annonc/mdt035.CrossRefPubMed

14.

Boehmer U, Glickman M, Winter M, Clark MA. Lesbian and bisexual women’s adjustment after a breast cancer diagnosis. J Am Psychiat Nurses. 2013;19(5):280–92. https://doi.org/10.1177/1078390313504587.CrossRef

15.

Boehmer U, Glickman M, Winter M, Clark MA. Long-term breast cancer survivors’ symptoms and morbidity: differences by sexual orientation? J Cancer Surviv. 2013;7(2):203–10. https://doi.org/10.1007/s11764-012-0260-8.CrossRefPubMed

16.

Boehmer U, Ozonoff A, Timm A, Winter M, Potter J. After breast cancer: sexual functioning of sexual minority survivors. J Sex Res. 2014;51(6):681–9. https://doi.org/10.1080/00224499.2013.772087.CrossRefPubMed

17.

Boehmer U, Tripodis Y, Bazzi AR, Winter M, Clark MA. Fear of cancer recurrence in survivor and caregiver dyads: differences by sexual orientation and how dyad members influence each other. J Cancer Surviv. 2016;10(5):802–13. https://doi.org/10.1007/s11764-016-0526-7.CrossRefPubMedPubMedCentral

18.

Boehmer U, Ozonoff A, Potter J. Sexual minority women’s health behaviors and outcomes after breast cancer. Lgbt Health. 2015;2(3):221–7. https://doi.org/10.1089/lgbt.2014.0105.CrossRefPubMed

19.

Boehmer U, Stokes JE, Bazzi AR, Clark MA. Dyadic quality of life among heterosexual and sexual minority breast cancer survivors and their caregivers. Support Care Cancer. 2020;28(6):2769–78. https://doi.org/10.1007/s00520-019-05148-7.CrossRefPubMed

20.

Jabson JM, Donatelle RJ, Bowen D. Breast cancer survivorship: the role of perceived discrimination and sexual orientation. J Cancer Surviv. 2011;5(1):92–101. https://doi.org/10.1007/s11764-010-0161-7.CrossRefPubMed

21.

Brown MT, McElroy JA. Unmet support needs of sexual and gender minority breast cancer survivors. Support Care Cancer. 2018;26(4):1189–96.CrossRefPubMed

22.

Brown MT, McElroy JA. Sexual and gender minority breast cancer patients choosing bilateral mastectomy without reconstruction: "I now have a body that fits me". Women Health. 2018;58(4):403–18. https://doi.org/10.1080/03630242.2017.1310169.CrossRefPubMed

23.

Matthews AK, Peterman AH, Delaney P, Menard L, Brandenburg D, editors. A qualitative exploration of the experiences of lesbian and heterosexual patients with breast cancer. Oncology Nursing Forum-Oncology Nursing Society. Pittsburgh: Oncology Nursing Society; 2002.

24.

White JL, Boehmer U. Long-term breast cancer survivors’ perceptions of support from female partners: an exploratory study. Oncol Nurs Forum. 2012;39(2):210-7. https://doi.org/10.1188/12.ONF.210-217.

25.

Jabson JM, Bowen DJ. Perceived stress and sexual orientation among breast cancer survivors. J Homosex. 2014;61(6):889–98. https://doi.org/10.1080/00918369.2014.870814.CrossRefPubMed

26.

Kamen C, Jabson JM, Mustian KM, Boehmer U. Minority stress, psychosocial resources, and psychological distress among sexual minority breast cancer survivors. Health Psychol. 2017;36(6):529–37. https://doi.org/10.1037/hea0000465.CrossRefPubMedPubMedCentral

27.

Wheldon CW, Roberts MC, Boehmer U. Differences in coping with breast cancer between lesbian and heterosexual women: a life course perspective. J Women's Health (Larchmt). 2019;28(8):1023–30. https://doi.org/10.1089/jwh.2018.6940.CrossRef

28.

Boehmer U, Glickman M, Winter M. Anxiety and depression in breast cancer survivors of different sexual orientations. J Consult Clin Psychol. 2012;80(3):382.CrossRefPubMed

29.

Boehmer U, White JL. Sexual minority status and long-term breast cancer survivorship. Women Health. 2012;52(1):71–87. https://doi.org/10.1080/03630242.2011.643349.CrossRefPubMed

30.

Boehmer U, Gereige J, Winter M, Ozonoff A. Cancer survivors’ access to care and quality of life: do sexual minorities fare worse than heterosexuals? Cancer-Am Cancer Soc. 2019;125(17):3079–85. https://doi.org/10.1002/cncr.32151.CrossRef

31.

Boehmer U, Miao XP, Ozonoff A. Cancer survivorship and sexual orientation. Cancer-Am Cancer Soc. 2011;117(16):3796–804. https://doi.org/10.1002/cncr.25950.CrossRef

32.

Bazzi AR, Clark MA, Winter MR, Ozonoff A, Boehmer U. Resilience among breast cancer survivors of different sexual orientations. Lgbt Health. 2018;5(5):295–302. https://doi.org/10.1089/lgbt.2018.0019.CrossRefPubMedPubMedCentral

33.

Jabson JM, Donatelle RJ, Bowen DJ. Relationship between sexual orientation and quality of life in female breast cancer survivors. J Women's Health (Larchmt). 2011;20(12):1819–24. https://doi.org/10.1089/jwh.2011.2921.CrossRef

34.

Jagervall CD, Bruggeman J, Johnson E. Gay men's experiences of sexual changes after prostate cancer treatment: A qualitative study in Sweden. Scand J Urol. 2019;53(1):40–4.CrossRef

35.

Crangle CJ, Latini DM, Hart TL. The effects of attachment and outness on illness adjustment among gay men with prostate cancer. Psycho-Oncology. 2017;26(4):500–7. https://doi.org/10.1002/pon.4043.CrossRefPubMed

36.

Ussher JM, Perz J, Rose D, Dowsett GW, Chambers S, Williams S, et al. Threat of sexual disqualification: the consequences of erectile dysfunction and other sexual changes for gay and bisexual men with prostate cancer. Arch Sex Behav. 2017;46(7):2043–57. https://doi.org/10.1007/s10508-016-0728-0.CrossRefPubMed

37.

Wassersug RJ, Lyons A, Duncan D, Dowsett GW, Pitts M. Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer. Urology. 2013;82(3):565–71. https://doi.org/10.1016/j.urology.2013.04.022.CrossRefPubMed

38.

Polter EJ, Wheldon CW, Rosser BRS, Kohli N, Capistrant BD, Kapoor A, et al. Health-related quality of life by human immunodeficiency virus status in a cross-sectional survey of gay and bisexual prostate cancer survivors. Psychooncology. 2019;28(12):2351–7. https://doi.org/10.1002/pon.5228.CrossRefPubMedPubMedCentral

39.

Motofei IG, Rowland DL, Popa F, Kreienkamp D, Paunica S. Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal. BJU Int. 2011;108(1):110–5. https://doi.org/10.1111/j.1464-410X.2010.09764.x.CrossRefPubMed

40.

Rosser BRS, Kohli N, Polter EJ, Lesher L, Capistrant BD, Konety BR, et al. The sexual functioning of gay and bisexual men following prostate cancer treatment: results from the restore study. Arch Sex Behav. 2020;49(5):1589–600.CrossRefPubMed

41.

Capistrant BD, Torres B, Merengwa E, West WG, Mitteldorf D, Rosser BR. Caregiving and social support for gay and bisexual men with prostate cancer. Psycho-Oncology. 2016;25(11):1329–36. https://doi.org/10.1002/pon.4249.CrossRefPubMedPubMedCentral

42.

Rosser BR, Capistrant B, Torres B, Konety B, Merengwa E, Mitteldorf D, et al. The effects of radical prostatectomy on gay and bisexual men’s mental health, sexual identity and relationships: qualitative results from the Restore Study. Sex Relation Ther. 2016;31(4):446–61. https://doi.org/10.1080/14681994.2016.1228871.CrossRefPubMedPubMedCentral

43.

Lee TK, Breau RH, Eapen L. Pilot study on quality of life and sexual function in men-who-have-sex-with-men treated for prostate cancer. J Sex Med. 2013;10(8):2094–100. https://doi.org/10.1111/jsm.12208.CrossRefPubMed

44.

McConkey RW, Holborn C. Exploring the lived experience of gay men with prostate cancer: a phenomenological study. Eur J Oncol Nurs. 2018;33:62–9. https://doi.org/10.1016/j.ejon.2018.01.013.CrossRefPubMed

45.

Hartman ME, Irvine J, Currie KL, Ritvo P, Trachtenberg L, Louis A, et al. Exploring gay couples' experience with sexual dysfunction after radical prostatectomy: a qualitative study. J Sex Marital Ther. 2014;40(3):233–53. https://doi.org/10.1080/0092623X.2012.726697.CrossRefPubMed

46.

Anderson BT, Danforth A, Daroff R, Stauffer C, Ekman E, Agin-Liebes G, et al. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. Eclinical Med. 2020;27:100557. https://doi.org/10.1016/j.eclinm.2020.100538.CrossRef

47.

Thomas C, Wootten A, Robinson P. The experiences of gay and bisexual men diagnosed with prostate cancer: results from an online focus group. Eur J Cancer Care. 2013;22(4):522–9. https://doi.org/10.1111/ecc.12058.CrossRef

48.

Boehmer U, Gereige J, Winter M, Ozonoff A, Scout N. Transgender individuals’ cancer survivorship: results of a cross-sectional study. Cancer. 2020. https://doi.org/10.1002/cncr.32784.

49.

Bryson MK, Taylor ET, Boschman L, Hart TL, Gahagan J, Rail G, et al. Awkward choreographies from cancer's margins: incommensurabilities of biographical and biomedical knowledge in sexual and/or gender minority cancer patients' treatment. J Med Humanit. 2018. https://doi.org/10.1007/s10912-018-9542-0.

50.

Kamen CS, Smith-Stoner M, Heckler CE, Flannery M, Margolies L. Social support, self-rated health, and lesbian, gay, bisexual, and transgender identity disclosure to cancer care providers. Oncol Nurs Forum. 2015;42(1):44–51. https://doi.org/10.1188/15.ONF.44-51.CrossRefPubMedPubMedCentral

51.

Lisy K, Ward A, Schofield P, Hulbert-Williams N, Bishop J, Jefford M. Patient-reported outcomes of sexual and gender minority cancer survivors in Australia. Psycho-Oncology. 2019;28(2):442–4. https://doi.org/10.1002/pon.4956.CrossRefPubMed

52.

Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001;20(1):20–32. https://doi.org/10.1037//0278-6133.20.1.20.CrossRefPubMed

53.

Frierson GM, Thiel DL, Andersen BL. Body change stress for women with breast cancer: the Breast-Impact of Treatment Scale. Ann Behav Med. 2006;32(1):77–81. https://doi.org/10.1207/s15324796abm3201_9.CrossRefPubMed

54.

Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595–605.CrossRefPubMed

55.

Schulz U, Schwarzer R. Soziale Unterstützung bei der Krankheitsbewältigung: Die Berliner Social Support Skalen (BSSS) [Social support in coping with illness: the Berlin Social Support Scales (BSSS)]. Diagnostica. 2003;49(2):73–82. https://doi.org/10.1026//0012-1924.49.2.73.CrossRef

56.

Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1996;48(5):773–7. https://doi.org/10.1016/s0090-4295(96)00226-9.CrossRefPubMed

57.

Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401. https://doi.org/10.1177/014662167700100306.CrossRef

58.

UCLA Center for Health Policy Research. California Health Interview Survey. 2012. http://healthpolicy.ucla.edu/chis/Pages/default.aspx. Accessed 5 Jan 2020.

59.

Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). J Sex Marital Ther. 2006;32(1):43–52. https://doi.org/10.1080/00926230500232909.CrossRefPubMed

60.

Spanier GB. Measuring dyadic adjustment: new scales for assessing the quality of marriage or similar dyads. J Marriage Fam. 1976;38(1):15–28. https://doi.org/10.2307/350547.CrossRef

61.

Robinson S, Kissane DW, Brooker J, Hempton C, Michael N, Fischer J, et al. Refinement and revalidation of the demoralization scale: the DSII—External validity. Cancer. 2016;122(14):2260–7.CrossRefPubMed

62.

Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA. Measuring patients’ perceptions of the outcomes of treatment for early prostate cancer. Med Care. 2003;41(8):923–36. https://doi.org/10.1097/00005650-200308000-00006.CrossRefPubMed

63.

Vinokur AD, van Ryn M. Social support and undermining in close relationships: their independent effects on the mental health of unemployed persons. J Pers Soc Psychol. 1993;65(2):350–9. https://doi.org/10.1037//0022-3514.65.2.350.CrossRefPubMed

64.

Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905. https://doi.org/10.1016/s0090-4295(00)00858-x.CrossRefPubMed

65.

Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920–8. https://doi.org/10.1016/S0090-4295(97)00459-7.CrossRefPubMed

66.

Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208. https://doi.org/10.1080/009262300278597.CrossRefPubMed

67.

Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.CrossRefPubMed

68.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.CrossRefPubMed

69.

Thoresen S, Tambs K, Hussain A, Heir T, Johansen V, Bisson JI. Brief measure of posttraumatic stress reactions: impact of Event Scale-6. Soc Psychiatry Psychiatr Epidemiol. 2010;45(3):405–12. https://doi.org/10.1007/s00127-009-0073-x.CrossRefPubMed

70.

Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–30. https://doi.org/10.1016/s0090-4295(97)00238-0.CrossRefPubMed

71.

Devins GM, Dion R, Pelletier LG, et al. Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings Scale. Med Care. 2001;39(10):1097–104. https://doi.org/10.1097/00005650-200110000-00007.CrossRefPubMed

72.

Cohen S, Hoberman HM. Positive events and social supports as buffers of life change stress. J Appl Soc Psychol. 1983;13(2):99–125. https://doi.org/10.1111/j.1559-1816.1983.tb02325.x.CrossRef

73.

Watson M, Law M, dos-Santos M, Greer S, Baruch J, Bliss JM. The mini MAC: further development of the mental adjustment to cancer scale. J Psychosoc Oncol. 1994;12(3):33–46. https://doi.org/10.1300/J077V12N03_03.CrossRef

74.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76. https://doi.org/10.1093/jnci/85.5.365.CrossRefPubMed

75.

Roth AJ, Rosenfeld B, Kornblith AB, Gibson C, Scher HI, Curley-Smart T, et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer-Am Cancer Soc. 2003;97(11):2910–8. https://doi.org/10.1002/cncr.11386.CrossRef

76.

Cash T. Manual for the Multidimensional Body-Self Relations Questionnaire (MBSRQ) (3rd rev.). 2000. http://www.body-images.com. Accessed 5 Jan 2020.

77.

Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM. The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. J Clin Epidemiol. 2012;65(10):1107–16.CrossRefPubMedPubMedCentral

78.

Rosen RC, Catania JA, Althof SE, Pollack LM, O'Leary M, Seftel AD, et al. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology. 2007;69(5):805–9. https://doi.org/10.1016/j.urology.2007.02.036.CrossRefPubMed

79.

Zimet GD, Dahlem NW, Zimet SG, Farley GK. Multidimensional scale of perceived social support (MSPSS). J Pers Assess. 1988;52(1):30–41. https://doi.org/10.1207/s15327752jpa5201_2.CrossRef

80.

Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Data. Atlanta: National Center for Health Statistics; 2008.

81.

Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1-3):163–73.CrossRefPubMed

82.

Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98(2):310–57.CrossRefPubMed

83.

Ferrell BR, Hassey-Dow K, Grant M. Quality of Life Patient/Cancer Survivor Version (QOL-CSV). 2012. www.midss.ie. Accessed 5 Jan 2020.

84.

Wagnild GM, Young HM. Development and psychometric evaluation of the Resilience Scale. J Nurs Meas. 1993;1(2):165–78.PubMed

85.

Bartholomew K, Horowitz LM. Attachment styles among young adults: a test of a four-category model. J Pers Soc Psychol. 1991;61(2):226–44. https://doi.org/10.1037//0022-3514.61.2.226.CrossRefPubMed

86.

Boyes A, Girgis A, Lecathelinais C. Brief assessment of adult cancer patients’ perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract. 2009;15(4):602–6. https://doi.org/10.1111/j.1365-2753.2008.01057.x.CrossRefPubMed

87.

Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33. https://doi.org/10.1097/00005650-199603000-00003.CrossRefPubMed

88.

Ware J, Kosinski M, Keller S. SF-36 physical and mental health summary scales: a user’s manual. Boston: The Health Institute, New England Medical Center; 1994.

89.

Spielberger C, Gorsuch R, Lushene R. The State-Trait Anxiety Inventory (STAI). Palo Alto: Consulting Psychologists Press; 1968.

90.

Anderson LA, Dedrick RF. Trust in Physician Scale (TPS). Measures for clinical practice: Vol. 2. Adults New York: The Free Press; 1990.

91.

Jabson JM, Farmer GW, Bowen DJ. Health behaviors and self-reported health among cancer survivors by sexual orientation. Lgbt Health. 2015;2(1):41–7. https://doi.org/10.1089/lgbt.2014.0038.CrossRefPubMedPubMedCentral

92.

Kamen C, Mustian KM, Dozier A, Bowen DJ, Li Y. Disparities in psychological distress impacting lesbian, gay, bisexual and transgender cancer survivors. Psycho-Oncology. 2015;24(11):1384–91. https://doi.org/10.1002/pon.3746.CrossRefPubMedPubMedCentral

93.

Torbit LA, Albiani JJ, Crangle CJ, Latini DM, Hart TL. Fear of recurrence: the importance of self-efficacy and satisfaction with care in gay men with prostate cancer. Psycho-Oncology. 2015;24(6):691–8. https://doi.org/10.1002/pon.3630.CrossRefPubMed

94.

Ussher JM, Perz J, Kellett A, Chambers S, Latini D, Davis ID, et al. Health-related quality of life, psychological distress, and sexual changes following prostate cancer: a comparison of gay and bisexual men with heterosexual men. J Sex Med. 2016;13(3):425–34. https://doi.org/10.1016/j.jsxm.2015.12.026.CrossRefPubMed

95.

Kamen C, Heckler C, Janelsins MC, Peppone LJ, McMahon JM, Morrow GR, et al. A dyadic exercise intervention to reduce psychological distress among lesbian, gay, and heterosexual cancer survivors. LGBT Health. 2016;3(1):57–64. https://doi.org/10.1089/lgbt.2015.0101.CrossRefPubMedPubMedCentral

96.

Hart TL, Coon DW, Kowalkowski MA, Zhang K, Hersom JI, Goltz HH, et al. Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers. J Sex Med. 2014;11(9):2308–17. https://doi.org/10.1111/jsm.12598.CrossRefPubMedPubMedCentral

97.

Hutchcraft ML, Teferra AA, Montemorano L, Patterson JG. Differences in health-related quality of life and health behaviors among lesbian, bisexual, and heterosexual women surviving cancer from the 2013 to 2018 National Health Interview Survey. LGBT Health. 2021;8(1):68–78.CrossRefPubMedPubMedCentral

98.

Sledge P. From decision to incision: Ideologies of gender in surgical cancer care. Soc Sci Med. 2019;239:112550. https://doi.org/10.1016/j.socscimed.2019.112550.CrossRefPubMed

99.

Desai MJ, Gold RS, Jones CK, Din H, Dietz AC, Shliakhtsitsava K, et al. Mental health outcomes in adolescent and young adult female cancer survivors of a sexual minority. JAYAO. 2020;00(00). https://doi.org/10.1089/jayao.2020.0082.

100.

Russell AM, Galvin KM, Harper MM, Clayman ML. A comparison of heterosexual and LGBTQ cancer survivors’ outlooks on relationships, family building, possible infertility, and patient-doctor fertility risk communication. J Cancer Surviv. 2016;10(5):935–42. https://doi.org/10.1007/s11764-016-0524-9.CrossRef

101.

Jabson JM, Taylor ET, Bryson MK. Cancer’s margins: trans* and gender nonconforming people’s access to knowledge, experiences of cancer health, and decision-making. LGBT Health. 2016;3:89.

102.

Rubin LR, Tanenbaum M. “Does that make me a woman?” Breast cancer, mastectomy, and breast reconstruction decisions among sexual minority women. Pscchol Women Q. 2011;35:401–14.CrossRef

103.

Reygan FC, D’Alton P. A pilot training programme for health and social care professionals providing oncological and palliative care to lesbian, gay and bisexual patients in Ireland. Psychooncology. 2013;22:1050–4.CrossRefPubMed

104.

Legere LE, MacDonnell JA. Meaningful support for lesbian and bisexual women navigating reproductive cancer care in Canada: an exploratory study. J Res Nurs. 2016;21:163–74.CrossRef

105.

Paul LB, Pitagora D, Brown B, Tworecke A, Rubin L. Support needs and resources of sexual minority women with breast cancer. Psychoncology. 2014;23:578–84.CrossRef

106.

Kamen CS, Blosnich J, Trevio L, Lytle M, Morrow G. Cigarette smoking disparities among sexual minority cancer survivors. Prev Med Rep. 2013;45:S251.

107.

Kent EE, Wheldon CW, Smith AW, Srinivasan S, Geiger AM. Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: a scoping review. Cancer-Am Cancer Soc. 2019;125(24):4371–9. https://doi.org/10.1002/cncr.32388.CrossRef

108.

Boehmer U, Stokes JE, Bazzi AR, Winter M, Clark MA. Dyadic stress of breast cancer survivors and their caregivers: are there differences by sexual orientation? Psycho-Oncology. 2018;27(10):2389–97. https://doi.org/10.1002/pon.4836.CrossRefPubMedPubMedCentral

109.

Baughman A, Clark MA, Boehmer U. Experiences and concerns of lesbian, gay, or bisexual survivors of colorectal cancer. Oncol Nurs Forum. 2017;44(3):350–7. https://doi.org/10.1188/17.ONF.350-357.CrossRefPubMedPubMedCentral

110.

Boehmer U, Clark MA, Ozonoff A, Winter M, Potter J. Survivors’ perceptions of quality of colorectal cancer care by sexual orientation. J Clin Oncol. 2020;43(9). https://doi.org/10.1097/COC.0000000000000732.

111.

Allensworth-Davies D, Talcott JA, Heeren T, de Vries B, Blank TO, Clark JA. The health effects of masculine self-esteem following treatment for localized prostate cancer among gay men. Lgbt Health. 2016;3(1):49–56. https://doi.org/10.1089/lgbt.2015.0090.CrossRefPubMedPubMedCentral

112.

Lee TK, Handy AB, Kwan W, Oliffe JL, Brotto LA, Wassersug RJ, et al. Impact of prostate cancer treatment on the sexual quality of life for men-who-have-sex-with-men. J Sex Med. 2015;12(12):2378–86. https://doi.org/10.1111/jsm.13030.CrossRefPubMed

113.

Hoyt MA, Frost DM, Cohn E, Millar BM, Diefenbach MA, Revenson TA. Gay men’s experiences with prostate cancer: implications for future research. J Health Psychol. 2020;25(3):298–310. https://doi.org/10.1177/1359105317711491.CrossRefPubMed

114.

Rosser BS, Konety BR, Mitteldorf D, Kohli N, Lesher L, West W, et al. What gay and bisexual men treated for prostate cancer are offered and attempt as sexual rehabilitation for prostate cancer: results from the Restore study. Urol Pract. 2018;5(3):187–91.CrossRefPubMedPubMedCentral

115.

Thomas C, Wootten AC, Robinson P, Law PCF, McKenzie DP. The impact of sexual orientation on body image, self-esteem, urinary and sexual functions in the experience of prostate cancer. Eur J Cancer Care. 2018;27(2):ARTN e12827. https://doi.org/10.1111/ecc.12827.CrossRef

116.

Wright MM, Schreiner P, Rosser BRS, Polter EJ, Mitteldorf D, West W, et al. The influence of companion animals on quality of life of gay and bisexual men diagnosed with prostate cancer. Int J Environ Res Public Health. 2019;16(22). https://doi.org/10.3390/ijerph16224457.

117.

Kamen C, Palesh O, Gerry AA, Andrykowski MA, Heckler C, Mohile S, et al. Disparities in health risk behavior and psychological distress among gay versus heterosexual male cancer survivors. Lgbt Health. 2014;1(2):86–U103. https://doi.org/10.1089/lgbt.2013.0022.CrossRefPubMed

118.

Matthews AK, Hotton A, Li CC, Miller K, Johnson A, Jones KW, et al. An internet-based study examining the factors associated with the physical and mental health quality of life of LGBT cancer survivors. Lgbt Health. 2016;3(1):65–73. https://doi.org/10.1089/lgbt.2014.0075.CrossRefPubMed

119.

Seay J, Mitteldorf D, Yankie A, Pirl WF, Kobetz E, Schlumbrecht M. Survivorship care needs among LGBT cancer survivors. J Psychosoc Oncol. 2018;36(4):393–405.CrossRefPubMed

Title: Health outcomes of sexual and gender minorities after cancer: a systematic review
Authors: Mandi L. Pratt-Chapman
Ash B. Alpert
Daniel A. Castillo
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Prostate Cancer
Prostate Cancer
Published in: Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI: https://doi.org/10.1186/s13643-021-01707-4

At a glance: The STEP trials

Springer Medicine

Health outcomes of sexual and gender minorities after cancer: a systematic review

Abstract

Purpose

Methods

Results

Conclusions

Implications for cancer survivors

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 1/2021

The ability of comorbidity indices to predict mortality in an orthopedic setting: a systematic review

AGREEing on clinical practice guidelines for idiopathic steroid-sensitive nephrotic syndrome in children

Molecular mechanisms of Zika virus teratogenesis from animal studies: a systematic review protocol

Integrated Risk Information System (IRIS) response to “Assessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools”

National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol

Endectocides as a complementary intervention in the malaria control program: a systematic review